Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Certoparin for Clotting Prophylaxis in Hemodialysis
NCT01179620Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of certoparin in thrombosis, sponsored by Novartis. Primary endpoint: Number of patients requiring uptitration at Week 8. Started Nov 2010; status: completed.
02
Drugs
certoparin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT01179620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01179620.